Objective: Spasms in patients with generalized tetanus can be suppress
ed by a spinal intrathecal infusion of baclofen. We report on four pat
ients and review reported cases treated by this method elsewhere. Desi
gn: Intrathecal baclofen infusion was started with a bolus dose (300-5
00 mu g) and continued at a steady rate of 500-1000 mu g/day. The dose
was increased in daily steps as needed. Results: Doses of baclofen of
500, 1000, or 2000 mu g/day were effective in three patients, while 1
500 mu g/day was insufficient in the fourth, Bradycardia and hypotonia
occurred in one patient at a dose of 2000 mu g/day but resolved after
the dose was reduced to 1500 mu g/day. Another patient developed hypo
tonia when a bolus of 500 mu g was given after a steady infusion of 15
00 mu g/day. Voluntary movements were preserved in one and returned in
two patients when sedation, induced by initial diazepam infusions, re
ceded. The fourth patient needed diazepam during most of the treatment
with intrathecal baclofen and required mechanical ventilation while b
eing treated with baclofen. Conclusions: A catheter position higher th
an T11 would possibly have yielded better results, It may be necessary
to adapt the dose during the course of the illness. The preservation
of respiratory drive and voluntary movements is the main advantage of
treating tetanus with intrathecal baclofen. Additionally it helps to r
educe sympathetic hyperactivity. Mortality may thereby be reduced.